Table 1

Description of cardioinhibition and arterial vasodepression in the response to carotid sinus massage

 Pure CI n = 69Pure aVD n = 23CI and aVD n = 44CI nor aVD n = 62P-value (CI)P-value (aVD)P-value (CI × aVD)
Age (years)65.0 ± 10.363.9 ± 11.463.4 ± 11.157.7 ± 13.20.0290.0880.014
M:F (n)38:3113:1030:1432:30
SBP fall ≥ 50 mmHg (n)171131a
Asystole ≥ 3 s (n)8060
Syncope last year (n; median IQR)1 (0–4)1 (0–1)1 (0–2)2 (0–4)
Latencies
 T-min SBP16.0 ± 10.115.9 ± 10.714.4 ± 7.919.8 ± 13.00.0440.220.74
 T-min MAP14.0 ± 9.114.4 ± 8.512.0 ± 4.615.7 ± 11.20.100.390.57
 T-min DBP13.7 ± 9.415.1 ± 8.713.8 ± 7.319.2 ± 3.20.00820.410.40
 T-min HR7.3 ± 6.111.1 ± 9.27.5 ± 4.914.5 ± 14.00.00020.190.15
 T-min TPR18.9 ± 10.318.8 ± 8.617.2 ± 5.717.6 ± 11.90.910.920.33
 T-max SV10.6 ± 10.112.5 ± 6.710.9 ± 6.417.8 ± 12.70.0130.160.12
Peak amplitudes
 Delta SBP35.0 ± 24.128.0 ± 16.639.4 ± 21.516.5 ± 13.8<0.00010.0570.64
 Delta MAP24.4 ± 16.520.1 ± 11.629.3 ± 15.510.2 ± 9.0<0.00010.00380.54
 Delta DBP18.7 ± 12.516.7 ± 8.724.5 ± 12.58.1 ± 7.0<0.00010.00020.82
 Delta HR25.2 ± 21.94.2 ± 4.023.4 ± 21.95.4 ± 5.8<0.00010.490.96
 Delta TPR0.26 ± 0.330.40 ± 0.200.44 ± 0.230.13 ± 0.150.029<0.00010.20
 Delta SV10.5 ± 10.511.6 ± 11.716.8 ± 12.24.8 ± 6.30.00120.00030.98
Sustained magnitude early period
 SusMagLR MAP−43.2 ± 55.8−29.7 ± 31.1−58.1 + 58.61.1 + 34.8<0.00010.00710.49
 SusMagLR HR−42.6 ± 40.72.4 ± 30.6−34.5 + 27.7−1.3 + 22.6<0.00010.190.71
 SusMagLR TPR1.9 ± 69.2−47.4 ± 44.6−53.8 + 51.915.0 + 50.90.62<0.00010.65
 SusMagLR SV−11.9 ± 62.923.0 ± 29.428.5 + 51.3−16.4 + 35.80.54<0.00010.73
Sustained magnitude late period
 Late SusMagLR MAP−2.4 ± 40.7−4.8 ± 2.5−1.0 ± 27.12.3 ± 32.80.770.710.54
 Late SusMagLR HR−7.5 ± 28.627.1 ± 42.7−6.1 ± 34.97.2 ± 34.7<0.00010.0660.11
 Late SusMagLR TPR9.9 ± 69.8−25.7 ± 44.7−12.7 ± 61.814.4 ± 61.00.280.00360.37
 Late SusMagLR SV−13.3 ± 57.7−0.90 ± 22.512.4 ± 63.2−22.0 ± 53.10.310.0210.67
 Pure CI n = 69Pure aVD n = 23CI and aVD n = 44CI nor aVD n = 62P-value (CI)P-value (aVD)P-value (CI × aVD)
Age (years)65.0 ± 10.363.9 ± 11.463.4 ± 11.157.7 ± 13.20.0290.0880.014
M:F (n)38:3113:1030:1432:30
SBP fall ≥ 50 mmHg (n)171131a
Asystole ≥ 3 s (n)8060
Syncope last year (n; median IQR)1 (0–4)1 (0–1)1 (0–2)2 (0–4)
Latencies
 T-min SBP16.0 ± 10.115.9 ± 10.714.4 ± 7.919.8 ± 13.00.0440.220.74
 T-min MAP14.0 ± 9.114.4 ± 8.512.0 ± 4.615.7 ± 11.20.100.390.57
 T-min DBP13.7 ± 9.415.1 ± 8.713.8 ± 7.319.2 ± 3.20.00820.410.40
 T-min HR7.3 ± 6.111.1 ± 9.27.5 ± 4.914.5 ± 14.00.00020.190.15
 T-min TPR18.9 ± 10.318.8 ± 8.617.2 ± 5.717.6 ± 11.90.910.920.33
 T-max SV10.6 ± 10.112.5 ± 6.710.9 ± 6.417.8 ± 12.70.0130.160.12
Peak amplitudes
 Delta SBP35.0 ± 24.128.0 ± 16.639.4 ± 21.516.5 ± 13.8<0.00010.0570.64
 Delta MAP24.4 ± 16.520.1 ± 11.629.3 ± 15.510.2 ± 9.0<0.00010.00380.54
 Delta DBP18.7 ± 12.516.7 ± 8.724.5 ± 12.58.1 ± 7.0<0.00010.00020.82
 Delta HR25.2 ± 21.94.2 ± 4.023.4 ± 21.95.4 ± 5.8<0.00010.490.96
 Delta TPR0.26 ± 0.330.40 ± 0.200.44 ± 0.230.13 ± 0.150.029<0.00010.20
 Delta SV10.5 ± 10.511.6 ± 11.716.8 ± 12.24.8 ± 6.30.00120.00030.98
Sustained magnitude early period
 SusMagLR MAP−43.2 ± 55.8−29.7 ± 31.1−58.1 + 58.61.1 + 34.8<0.00010.00710.49
 SusMagLR HR−42.6 ± 40.72.4 ± 30.6−34.5 + 27.7−1.3 + 22.6<0.00010.190.71
 SusMagLR TPR1.9 ± 69.2−47.4 ± 44.6−53.8 + 51.915.0 + 50.90.62<0.00010.65
 SusMagLR SV−11.9 ± 62.923.0 ± 29.428.5 + 51.3−16.4 + 35.80.54<0.00010.73
Sustained magnitude late period
 Late SusMagLR MAP−2.4 ± 40.7−4.8 ± 2.5−1.0 ± 27.12.3 ± 32.80.770.710.54
 Late SusMagLR HR−7.5 ± 28.627.1 ± 42.7−6.1 ± 34.97.2 ± 34.7<0.00010.0660.11
 Late SusMagLR TPR9.9 ± 69.8−25.7 ± 44.7−12.7 ± 61.814.4 ± 61.00.280.00360.37
 Late SusMagLR SV−13.3 ± 57.7−0.90 ± 22.512.4 ± 63.2−22.0 ± 53.10.310.0210.67

Local minima of HR and TPR were ‘overt’ when their amplitude was lower than 3 SD below the mean of baseline for SBP, MAP, HR, and TPR and higher for SV. Massages were divided into four combinations of presence or absence of overt peaks for HR and TPR: ‘pure CI’ means overt HR and obscure TPR; ‘overt aVD’ means obscure HR and overt TPR; ‘both CI and aVD’ means overt HR and overt TPR; and ‘CI nor aVD’ means obscure HR and obscure TPR. Logratio values are shown after multiplication by 1000 to help appreciate their relative sizes. P-values represent ANOVA with the factor CI (present or absent) and aVD (present of absent) and their interaction.

Delta, difference between period of interest and baseline period; SusMagLR, sustained magnitude in logratio units.

aThis case represents a combination of HR and TPR decreases that were 2.5 and 2.6 SD away from the mean, so neither reached the threshold to be recognized as CI or aVD.

Table 1

Description of cardioinhibition and arterial vasodepression in the response to carotid sinus massage

 Pure CI n = 69Pure aVD n = 23CI and aVD n = 44CI nor aVD n = 62P-value (CI)P-value (aVD)P-value (CI × aVD)
Age (years)65.0 ± 10.363.9 ± 11.463.4 ± 11.157.7 ± 13.20.0290.0880.014
M:F (n)38:3113:1030:1432:30
SBP fall ≥ 50 mmHg (n)171131a
Asystole ≥ 3 s (n)8060
Syncope last year (n; median IQR)1 (0–4)1 (0–1)1 (0–2)2 (0–4)
Latencies
 T-min SBP16.0 ± 10.115.9 ± 10.714.4 ± 7.919.8 ± 13.00.0440.220.74
 T-min MAP14.0 ± 9.114.4 ± 8.512.0 ± 4.615.7 ± 11.20.100.390.57
 T-min DBP13.7 ± 9.415.1 ± 8.713.8 ± 7.319.2 ± 3.20.00820.410.40
 T-min HR7.3 ± 6.111.1 ± 9.27.5 ± 4.914.5 ± 14.00.00020.190.15
 T-min TPR18.9 ± 10.318.8 ± 8.617.2 ± 5.717.6 ± 11.90.910.920.33
 T-max SV10.6 ± 10.112.5 ± 6.710.9 ± 6.417.8 ± 12.70.0130.160.12
Peak amplitudes
 Delta SBP35.0 ± 24.128.0 ± 16.639.4 ± 21.516.5 ± 13.8<0.00010.0570.64
 Delta MAP24.4 ± 16.520.1 ± 11.629.3 ± 15.510.2 ± 9.0<0.00010.00380.54
 Delta DBP18.7 ± 12.516.7 ± 8.724.5 ± 12.58.1 ± 7.0<0.00010.00020.82
 Delta HR25.2 ± 21.94.2 ± 4.023.4 ± 21.95.4 ± 5.8<0.00010.490.96
 Delta TPR0.26 ± 0.330.40 ± 0.200.44 ± 0.230.13 ± 0.150.029<0.00010.20
 Delta SV10.5 ± 10.511.6 ± 11.716.8 ± 12.24.8 ± 6.30.00120.00030.98
Sustained magnitude early period
 SusMagLR MAP−43.2 ± 55.8−29.7 ± 31.1−58.1 + 58.61.1 + 34.8<0.00010.00710.49
 SusMagLR HR−42.6 ± 40.72.4 ± 30.6−34.5 + 27.7−1.3 + 22.6<0.00010.190.71
 SusMagLR TPR1.9 ± 69.2−47.4 ± 44.6−53.8 + 51.915.0 + 50.90.62<0.00010.65
 SusMagLR SV−11.9 ± 62.923.0 ± 29.428.5 + 51.3−16.4 + 35.80.54<0.00010.73
Sustained magnitude late period
 Late SusMagLR MAP−2.4 ± 40.7−4.8 ± 2.5−1.0 ± 27.12.3 ± 32.80.770.710.54
 Late SusMagLR HR−7.5 ± 28.627.1 ± 42.7−6.1 ± 34.97.2 ± 34.7<0.00010.0660.11
 Late SusMagLR TPR9.9 ± 69.8−25.7 ± 44.7−12.7 ± 61.814.4 ± 61.00.280.00360.37
 Late SusMagLR SV−13.3 ± 57.7−0.90 ± 22.512.4 ± 63.2−22.0 ± 53.10.310.0210.67
 Pure CI n = 69Pure aVD n = 23CI and aVD n = 44CI nor aVD n = 62P-value (CI)P-value (aVD)P-value (CI × aVD)
Age (years)65.0 ± 10.363.9 ± 11.463.4 ± 11.157.7 ± 13.20.0290.0880.014
M:F (n)38:3113:1030:1432:30
SBP fall ≥ 50 mmHg (n)171131a
Asystole ≥ 3 s (n)8060
Syncope last year (n; median IQR)1 (0–4)1 (0–1)1 (0–2)2 (0–4)
Latencies
 T-min SBP16.0 ± 10.115.9 ± 10.714.4 ± 7.919.8 ± 13.00.0440.220.74
 T-min MAP14.0 ± 9.114.4 ± 8.512.0 ± 4.615.7 ± 11.20.100.390.57
 T-min DBP13.7 ± 9.415.1 ± 8.713.8 ± 7.319.2 ± 3.20.00820.410.40
 T-min HR7.3 ± 6.111.1 ± 9.27.5 ± 4.914.5 ± 14.00.00020.190.15
 T-min TPR18.9 ± 10.318.8 ± 8.617.2 ± 5.717.6 ± 11.90.910.920.33
 T-max SV10.6 ± 10.112.5 ± 6.710.9 ± 6.417.8 ± 12.70.0130.160.12
Peak amplitudes
 Delta SBP35.0 ± 24.128.0 ± 16.639.4 ± 21.516.5 ± 13.8<0.00010.0570.64
 Delta MAP24.4 ± 16.520.1 ± 11.629.3 ± 15.510.2 ± 9.0<0.00010.00380.54
 Delta DBP18.7 ± 12.516.7 ± 8.724.5 ± 12.58.1 ± 7.0<0.00010.00020.82
 Delta HR25.2 ± 21.94.2 ± 4.023.4 ± 21.95.4 ± 5.8<0.00010.490.96
 Delta TPR0.26 ± 0.330.40 ± 0.200.44 ± 0.230.13 ± 0.150.029<0.00010.20
 Delta SV10.5 ± 10.511.6 ± 11.716.8 ± 12.24.8 ± 6.30.00120.00030.98
Sustained magnitude early period
 SusMagLR MAP−43.2 ± 55.8−29.7 ± 31.1−58.1 + 58.61.1 + 34.8<0.00010.00710.49
 SusMagLR HR−42.6 ± 40.72.4 ± 30.6−34.5 + 27.7−1.3 + 22.6<0.00010.190.71
 SusMagLR TPR1.9 ± 69.2−47.4 ± 44.6−53.8 + 51.915.0 + 50.90.62<0.00010.65
 SusMagLR SV−11.9 ± 62.923.0 ± 29.428.5 + 51.3−16.4 + 35.80.54<0.00010.73
Sustained magnitude late period
 Late SusMagLR MAP−2.4 ± 40.7−4.8 ± 2.5−1.0 ± 27.12.3 ± 32.80.770.710.54
 Late SusMagLR HR−7.5 ± 28.627.1 ± 42.7−6.1 ± 34.97.2 ± 34.7<0.00010.0660.11
 Late SusMagLR TPR9.9 ± 69.8−25.7 ± 44.7−12.7 ± 61.814.4 ± 61.00.280.00360.37
 Late SusMagLR SV−13.3 ± 57.7−0.90 ± 22.512.4 ± 63.2−22.0 ± 53.10.310.0210.67

Local minima of HR and TPR were ‘overt’ when their amplitude was lower than 3 SD below the mean of baseline for SBP, MAP, HR, and TPR and higher for SV. Massages were divided into four combinations of presence or absence of overt peaks for HR and TPR: ‘pure CI’ means overt HR and obscure TPR; ‘overt aVD’ means obscure HR and overt TPR; ‘both CI and aVD’ means overt HR and overt TPR; and ‘CI nor aVD’ means obscure HR and obscure TPR. Logratio values are shown after multiplication by 1000 to help appreciate their relative sizes. P-values represent ANOVA with the factor CI (present or absent) and aVD (present of absent) and their interaction.

Delta, difference between period of interest and baseline period; SusMagLR, sustained magnitude in logratio units.

aThis case represents a combination of HR and TPR decreases that were 2.5 and 2.6 SD away from the mean, so neither reached the threshold to be recognized as CI or aVD.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close